A Brave New World
The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement
Case Report
Intravitreal Bevacizumab in a Silicone-filled Eye
Coding Q & A
Audit-causing issues in the retina practice
Controversies in Care
Avastin vs Lucentis for the treatment of neovascular AMD
Diabetic Retinopathy: The Masqueraders
Clinical hallmarks of DR can be associated with a variety of diseases
Focus On
The InVitria injection assistant
Great Debates in RVO Therapy
An anti-VEGF and steroid gain FDA sanction, but many clinical questions remain
How Baseline Assessment of AMD Lesion Type Influences Clinical Decisions and Outcomes
Careful diagnosis and phenotyping of neovascular AMD patients is still required in the anti-VEGF era
Journal Club
Studies to stimulate discussion and debate
Microperimetry and Pituitary Adenoma
Benign tumors can present as retinal symptoms
Subspecialty News
Small study jumps the gun on CATT; Data on PDT/Lucentis combinations; Radiation as a supplement to Anti-VEGF; and more
Upfront: From the Editor-in-Chief
Shortcuts
Visualization Agents for Vitreoretinal Surgery
Intraoperative dyes can be a useful adjunct, but what are the pros and cons? Surgeons share their insights